4-Hydroxy-L-phenylglycine; H-Phg(4-OH)-OH; L-4-Hydroxyphenylglycine; (S)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID; (S)-Amino-(4-hydroxyphenyl)acetic acid; (2s)-Amino(4-Hydroxyphenyl)Acetic Acid; (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid; UNII-9YH0WH2Z02; L-2-(p-Hydroxyphenyl)glycine; L-2-(4-Hydroxyphenyl)glycine; (2S)-amino(4-hydroxyphenyl)ethanoic acid; Oxfenicine (USAN/INN); L-P-HYDROXYPHENYGLYCINE; 9YH0WH2Z02; UK-25842; UK-25,842; DSSTox_CID_26403; DSSTox_RID_81583; DSSTox_GSID_46403; Oxfenicina; Oxfenicinum; (S)-4-hydroxyphenylglycine; Oxfenicinum [INN-Latin]; p-Hydroxy-L-phenylglycine; Oxfenicina [INN-Spanish]; L-(+)-A-4-HYDROXYPHENYLGLYCINE; Oxfenicine [USAN:INN:BAN]; MFCD00065932; NCGC00164509-01; EINECS 251-061-7; PubChem13975; UK 25842; (S)-alpha-Amino-4-hydroxybenzeneacetic acid; (S)-2-Amino-2-(4-hydroxyphenyl)essigsaeure; bmse000629; SCHEMBL122315; (s)-(4-hydroxyphenyl)glycine; Benzeneacetic acid, alpha-amino-4-hydroxy-, (alphaS)-; CHEMBL1232077; DTXSID3046403; CTK4G8744; KS-00000MKP; 4-Hydroxy-L-(+)-2-phenylglycine; ACT05092; ZINC6667724; Tox21_112144; ANW-48447; BDBM50403035; L-(+)-2-(4-Hydroxyphenyl)glycine; AKOS016842371; Tox21_112144_1; CS-W018812; DB04291; HY-W018026; NCGC00344518-01; AC-24628; BR-28583; DS-11081; SC-20695; W5427; 4-Hydroxy-L-phenylglycine, >=99.0% (NT); C12323; D05292; S-1484; Benzeneacetic acid, a-amino-4-hydroxy-, (aS)-; (2S)-2-azanyl-2-(4-hydroxyphenyl)ethanoic acid; A821286; Benzeneacetic acid, alpha-amino-4-hydroxy-, (S)-; (S)-(+)-2-Amino-2-(4-hydroxyphenyl)acetic Acid; J-018746; Q27095113; UNII-7UYG7X0F53 component LJCWONGJFPCTTL-ZETCQYMHSA-N